Lisa Patel

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe et al. · Biochemistry · 2002 · 558 citations

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Joseph J. Eron, Patrick Yéni, Joseph Gathe et al. · The Lancet · 2006 · 341 citations

Klean Study, Treatment And Prevention, Hiv Infection +9

Climate Change and Extreme Heat Events: How Health Systems Should Prepare

Lisa Patel, Kathryn C. Conlon, Cecilia Sorensen et al. · NEJM Catalyst · 2022 · 100 citations

Engineering, Climate Epidemiology, Climate Crisis +19

Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients

Kathleen Squires, Benjamin Young, Edwin DeJesus et al. · AIDS · 2010 · 66 citations

Safety and Efficacy of a 36-Week Induction Regimen of Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir in HIV-Infected Patients

Kathleen Squires, Benjamin Young, Edwin DeJesus et al. · HIV Clinical Trials · 2010 · 25 citations